Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
1. Details of issuer Biotest AG Landsteinerstraße 5 63303 Dreieich Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason:Exercise of financial instruments 3. Details of person subject to the notification obligation Name: City and country of registered office: UBS Group AG ZurichSwitzerland 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached: 17 Oct 2017 6. Total positions % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 0.03 % 0.00 % 0.03 % 19785726 Previous notification 0.03 % 5.22 % 5.25 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in % direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE0005227201 0 3558 0 % 0.02 % DE000A2E4TS2 0 2647 0 % 0.01 % Total 6205 0.03 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % % Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % % Total % 8. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) UBS Group AG % % % UBS AG % % % UBS Asset Management AG % % % UBS Asset Management Holding (No. 2) Ltd. % % % UBS Asset Management Holding Ltd % % % UBS Asset Management (UK) Ltd % % % UBS Group AG % % % UBS AG % % % UBS Asset Management AG % % % UBS Fund Management (Luxembourg) S.A. % % % UBS Group AG % % % UBS AG % % % UBS Asset Mangement AG % % % UBS Fund Management (Switzerland) AG % % % 9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks:Decrease of Trading Book Holdings below 5%.
24.10.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Biotest AG Landsteinerstraße 5 63303 Dreieich
Germany Internet: http://www.biotest.de End of News DGAP News Service